-
Product Insights
Haemophilus influenzae Type B Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Haemophilus influenzae Type B Infections - Drugs In Development, 2023’, provides an overview of the Haemophilus influenzae Type B Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Haemophilus influenzae Type B Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...